Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.64 Insider Own31.33% Shs Outstand127.46M Perf Week2.71%
Market Cap905.29M Forward P/E- EPS next Y-2.82 Insider Trans-0.05% Shs Float91.15M Perf Month10.80%
Income-329.12M PEG- EPS next Q-0.73 Inst Own72.51% Short Float13.04% Perf Quarter-32.87%
Sales35.33M P/S25.62 EPS this Y-1.73% Inst Trans1.46% Short Ratio9.59 Perf Half Y-15.49%
Book/sh5.64 P/B1.21 EPS next Y0.65% ROA-35.03% Short Interest11.89M Perf Year-41.05%
Cash/sh5.65 P/C1.21 EPS next 5Y- ROE-40.40% 52W Range5.70 - 13.32 Perf YTD-38.06%
Dividend Est.- P/FCF- EPS past 5Y-38.74% ROI-41.51% 52W High-48.80% Beta1.69
Dividend TTM- Quick Ratio20.73 Sales past 5Y319.82% Gross Margin84.53% 52W Low19.65% ATR (14)0.53
Dividend Ex-Date- Current Ratio20.73 EPS Y/Y TTM5.78% Oper. Margin-1045.73% RSI (14)49.15 Volatility8.44% 8.40%
Employees323 Debt/Eq0.07 Sales Y/Y TTM2873.74% Profit Margin-931.62% Recom1.09 Target Price23.10
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q19.93% Payout- Rel Volume0.53 Prev Close6.98
Sales Surprise8233.33% EPS Surprise14.69% Sales Q/Q4327.88% EarningsMay 02 AMC Avg Volume1.24M Price6.82
SMA201.13% SMA50-2.58% SMA200-22.30% Trades Volume653,481 Change-2.29%
Date Action Analyst Rating Change Price Target Change
May-10-24Upgrade Barclays Equal Weight → Overweight $15
Apr-20-23Upgrade Jefferies Underperform → Hold $12.50
Apr-19-23Upgrade Raymond James Outperform → Strong Buy $29
Apr-13-23Initiated Raymond James Outperform $29
Feb-03-23Initiated Oppenheimer Outperform $33
Sep-30-22Initiated Barclays Equal Weight $23
Sep-02-22Initiated Stifel Buy $40
Jun-06-22Initiated Jefferies Underperform $13
Feb-01-22Initiated Berenberg Buy $45
Jul-21-21Initiated BofA Securities Buy $50
May-21-24 04:05PM
May-13-24 08:30AM
May-10-24 10:01AM
May-06-24 08:57AM
May-02-24 09:55PM
05:55PM Loading…
Apr-25-24 04:05PM
Apr-11-24 04:05PM
Mar-17-24 05:20PM
Mar-15-24 12:39PM
Mar-13-24 09:55AM
Feb-26-24 04:05PM
04:40PM Loading…
Feb-22-24 04:40PM
Feb-15-24 04:05PM
Feb-01-24 04:05PM
Jan-18-24 05:37AM
Jan-08-24 07:00AM
Jan-02-24 04:05PM
Nov-30-23 09:55AM
Nov-14-23 09:55AM
Nov-07-23 04:05PM
Nov-02-23 06:21PM
Oct-31-23 12:00PM
04:05PM Loading…
Oct-26-23 04:05PM
Oct-12-23 04:05PM
Sep-18-23 04:05PM
Aug-31-23 10:16PM
Aug-08-23 06:05PM
Aug-01-23 04:05PM
May-25-23 05:01PM
May-24-23 04:05PM
May-18-23 08:16AM
May-04-23 07:25PM
Apr-27-23 04:05PM
Apr-21-23 02:48PM
Apr-20-23 02:20AM
Apr-19-23 07:30AM
Apr-18-23 10:40AM
Apr-14-23 05:05AM
Apr-13-23 06:12PM
Apr-07-23 07:44AM
Apr-06-23 09:55AM
Mar-06-23 07:30AM
Mar-01-23 07:30AM
Feb-25-23 07:31AM
Feb-23-23 05:45PM
Feb-21-23 10:00AM
Feb-16-23 04:05PM
Feb-07-23 05:01PM
Feb-02-23 07:30AM
Jan-13-23 11:11AM
Jan-03-23 07:30AM
Dec-31-22 08:53AM
Nov-24-22 08:02AM
Nov-17-22 01:58PM
Nov-07-22 07:30AM
Nov-03-22 06:35PM
Oct-27-22 04:05PM
Oct-14-22 10:14AM
Sep-26-22 07:30AM
Sep-23-22 07:30AM
Sep-12-22 09:30PM
Sep-11-22 09:45AM
Sep-08-22 04:06PM
Aug-30-22 11:15AM
Aug-25-22 02:48PM
Aug-18-22 04:05PM
Aug-04-22 04:05PM
Jul-28-22 04:05PM
Jun-27-22 06:00AM
Jun-16-22 07:30AM
May-26-22 07:30AM
May-07-22 09:59AM
May-05-22 04:05PM
May-03-22 07:30AM
Apr-28-22 04:05PM
Feb-24-22 04:05PM
Feb-17-22 04:05PM
Feb-10-22 11:51AM
Feb-02-22 07:30AM
Jan-04-22 07:30AM
Jan-03-22 07:30AM
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bergstrom Donald APresident, R&DApr 29 '24Sale6.382,68617,137527,427Apr 29 08:30 PM
Catinazzo ThomasChief Financial OfficerApr 29 '24Sale6.381,69510,814339,803Apr 29 08:31 PM
Adams BrianChief Legal OfficerApr 29 '24Sale6.381,62310,355325,767Apr 29 08:33 PM
Rahmer PeterSee remarksApr 29 '24Sale6.381,3458,581513,334Apr 29 08:36 PM
Bergstrom Donald APresident, R&DMar 27 '24Sale7.707655,890530,113Mar 29 04:15 PM
Catinazzo ThomasChief Financial OfficerMar 27 '24Sale7.703482,680341,498Mar 29 04:15 PM
Adams BrianChief Legal OfficerMar 27 '24Sale7.703482,680327,390Mar 29 04:15 PM
Rahmer PeterSee remarksMar 27 '24Sale7.702982,295514,679Mar 29 04:15 PM
Bergstrom Donald APresident, R&DJan 29 '24Sale9.643,17830,636530,878Jan 31 04:08 PM
Catinazzo ThomasChief Financial OfficerJan 29 '24Sale9.642,00519,328341,846Jan 31 04:11 PM
Adams BrianChief Legal OfficerJan 29 '24Sale9.641,92918,596327,738Jan 31 04:05 PM
Rahmer PeterSee remarksJan 29 '24Sale9.641,65115,916514,977Jan 31 04:14 PM
Bergstrom Donald APresident, R&DDec 27 '23Sale11.5197711,245234,056Dec 29 04:17 PM
Catinazzo ThomasChief Financial OfficerDec 27 '23Sale11.512943,384143,851Dec 29 04:22 PM
Adams BrianChief Legal OfficerDec 27 '23Sale11.512943,384129,667Dec 29 04:14 PM
Rahmer PeterSee remarksDec 27 '23Sale11.512442,808316,628Dec 29 04:26 PM
Bergstrom Donald APresident, R&DOct 30 '23Sale6.033,45120,810235,033Nov 01 04:14 PM
Catinazzo ThomasChief Financial OfficerOct 30 '23Sale6.031,69710,233144,145Nov 01 04:18 PM
Adams BrianChief Legal OfficerOct 30 '23Sale6.031,6329,841129,961Nov 01 04:07 PM
Rahmer PeterSee remarksOct 30 '23Sale6.031,3548,165316,872Nov 01 04:21 PM
Bergstrom Donald APresident, R&DSep 27 '23Sale8.386485,430238,484Sep 29 04:52 PM
Catinazzo ThomasChief Financial OfficerSep 27 '23Sale8.382942,464145,842Sep 29 04:22 PM
Adams BrianChief Legal OfficerSep 27 '23Sale8.382942,464131,593Sep 29 04:10 PM
Rahmer PeterSee remarksSep 27 '23Sale8.382442,045318,226Sep 29 04:32 PM
Bergstrom Donald APresident, R&DJul 28 '23Sale11.802,68331,659237,904Jul 31 04:48 PM
Catinazzo ThomasChief Financial OfficerJul 28 '23Sale11.801,69319,977146,136Jul 31 04:50 PM
Adams BrianChief Legal OfficerJul 28 '23Sale11.801,62819,210131,887Jul 31 04:46 PM
Rahmer PeterSee remarksJul 28 '23Sale11.801,35215,954316,808Jul 31 04:52 PM
Bergstrom Donald APresident, R&DJun 27 '23Sale12.126477,842240,587Jun 28 05:06 PM
Adams BrianChief Legal OfficerJun 27 '23Sale12.122943,563133,515Jun 28 05:02 PM
Catinazzo ThomasChief Financial OfficerJun 27 '23Sale12.122943,563147,829Jun 28 05:08 PM
Rahmer PeterSee remarksJun 27 '23Sale12.122442,957318,160Jun 28 05:12 PM